Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Cardiac contractility modulation wikipedia , lookup
DiGeorge syndrome wikipedia , lookup
Turner syndrome wikipedia , lookup
Down syndrome wikipedia , lookup
Coronary artery disease wikipedia , lookup
Hypertrophic cardiomyopathy wikipedia , lookup
Myocardial infarction wikipedia , lookup
Quantium Medical Cardiac Output wikipedia , lookup
Management of acute coronary syndrome wikipedia , lookup
Ventricular fibrillation wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
EDITORIAL Europace (2009) 11, 697–700 doi:10.1093/europace/eup081 Takotsubo cardiomyopathy and the long-QT syndrome: an insult to repolarization reserve Elijah R. Behr 1* and Saagar Mahida2 1 Cardiac and Vascular Division, St George’s University of London, London SW17 0RE, UK; and 2Leeds General Infirmary, Leeds, UK Received 9 March 2009; accepted after revision 10 March 2009; online publish-ahead-of-print 6 April 2009 This editorial refers to ‘A fatal combination in an old lady: Tako-Tsubo cardiomyopathy, long QT syndrome, and cardiac hypertrophy’ by H. Wedekind et al., on page 820 Torsades de pointes and QTc prolongation as a predictor of risk More recent case reports have emerged that document TdP in patients with TCM. Table 1 describes the 11 reported cases currently published in the English language. The mean age of these individuals at presentation was 63 years (range 22 –87), and the majority were female [9/11 (82%)]. This is similar to the several series described in Bybee et al.’s review whose mean age ranged from 62 to 75 years and whose female proportion ranged from 82 to 100%.1 In TdP cases, in whom the data were available, the mean QTc at presentation was 595ms, the mean maximal QTc recorded was 706ms, and the mean post-TCM QTc was 481ms (Table 2). Comparing paired data where available (paired Student’s t-test), the maximal QTc was significantly greater than the presenting QTc (P ¼ 0.0075) and the post-TCM QTc (P ¼ 0.0003), in keeping with Koji’s findings of variation of QT interval between acute, subacute, and chronic phases.7 None of these individuals were on QT prolonging drugs as far as can be ascertained. Comparison to the series where TdP was not identified (Table 2) suggests that the QT prolongation described in the TdP cases is greater. Desmet et al.’s6 series reports individuals’ acute phase QTc intervals and allows a direct comparison to be made (Table 2). The presenting and maximal QTc intervals in the TdP cases are significantly longer suggesting this as an association The opinions expressed in this article are not necessarily those of the Editors of Europace or of the European Society of Cardiology. * Corresponding author. Tel: þ44 2087255939, Fax: þ44 2087253328, Email: [email protected] Published on behalf of the European Society of Cardiology. All rights reserved. & The Author 2009. For permissions please email: [email protected]. Downloaded from by guest on October 14, 2016 Takotsubo cardiomyopathy (TCM) is a transient syndrome with acute, subacute, and chronic phases, and is commonly induced by emotional or physical stress. It is characterized by chest pain, electrocardiogram (ECG) changes, and minimal myocardial enzymatic release mimicking acute myocardial infarction in patients with unobstructed coronary arteries on angiography. Assessment of left ventricular function in patients with TCM reveals apical ballooning and hypokinesia with the preservation of basal contraction. Electrocardiogram changes include ST-segment elevation, the evolution of marked anterior T-wave inversion, and prolongation of the QT interval. These features all appear to resolve with time.1 Wedekind et al. 2 report a case of clinically silent pre-existing long-QT syndrome (LQTS) exacerbated by TCM and resulting in life-threatening arrhythmias. This mirrors our own description last year of a similar case3 and prompts an evaluation of the true significance of QT prolongation in this context. The association between TCM and QT prolongation has been well documented (Table 2). Seth et al. 4 reported 12 cases of TCM with an average QTc interval of 478ms. Similarly, Abe et al. 5 described 17 patients, most of whom had a prolonged QTc interval in the acute and subacute phases of the condition. The QT interval normalized in all cases between 97 and 191 days from the onset of symptoms. As part of a report on 13 patients by Desmet et al.,6 each patient’s ECG during the acute phase was described with QTc intervals ranging from 310 to 674ms. Koji et al. specifically evaluated the QT interval in 10 consecutive cases of TCM although individual patients’ measurements were not detailed. They demonstrated mean maximal QTc intervals in the acute (475 + 46ms), subacute (555 + 46ms), and chronic phases (444 + 41ms) of the condition.7 The subacute phase QTc was significantly prolonged compared with acute and chronic phases. It was, therefore, proposed that this temporary QT prolongation reflects the transient myocardial insult of TCM.7 Despite these consistent findings, ventricular arrhythmias in patients with TCM are relatively uncommon. In a review of seven case series containing a total of 180 cases, Bybee et al. 1 reported a 1–1.5% incidence of ventricular arrhythmias. In a more recent series of 14 patients, Bonello et al. 8 reported two cases of malignant ventricular arrhythmias (one patient with ventricular tachycardia and the other with ventricular fibrillation). A number of individual case reports have also documented the incidence of ventricular tachycardia and ventricular fibrillation in patients with TCM. None of these described, however, the presence of torsades de pointes (TdP). 698 Table 1 Case reports of Takotsubo cardiomyopathy and torsades de pointes Reference Age M/F PMH FH SD FH LQTS Prior syncope QT prolonging medications Presenting QTc Max QTc (ms) (ms) Post-QTc (ms) (after X days) Outcome Genetic testing ............................................................................................................................................................................................................................................. Wedekind et al. 2 81 F Prior QTc prolongation (520 ms), pacemaker, and hypertension Yes Yes No No 690 690 NS ICD implanted No Mahida et al. 3 55 F Diabetes and hyperlipidaemia No No Yes No 510 735 490 (56) Discharged ICD declined Yes b-Blocker Discharged Kurisu et al. 9 87 F None No No Yes NS 640a 880 440 (6) Kurisu et al. 9 78 M NS No No No NS 640a 920 600 (7) Ghosh et al. 10 59 F No No No NS NS 669 Normal (NS) Discharged Discharged No Furushima et al. 11 61 F Anxiety, hypertension, and alcohol excess NS No No No NS 740 740 470 (168) ICD implanted No Pacemaker implanted No Discharged Pacemaker implanted No b-Blocker Discharged Sasaki et al. 12 22 F NS No No No No 730 730 520 (22) Mexilitine Discharged No Denney et al. 13 32 M Obesity, migraine, asthma, Yes and rhinitis No No Nob 416 467 406 (4) b-Blocker No F None No No No 630c 727 440 (NS) ICD implanted No No Discharged Mofrad et al. 14 70 No Nault et al. 15 76 M None No No No No 630 786 Normal (2) Discharged Discharged Finstere et al. 16 75 F Mitochondrial disorder No No No NS 326d 425d NS b-Blocker No Death prior to discharge Editorial NS, not specified; PMH, previous medical history; FH, family history; TCM, Takotsubo cardiomyopathy; LQTS, long-QT syndrome; SD, sudden death. a In the presence of high-degree AV Block. b Patient receiving pseudoephedrine. c In the presence of hypokalaemia. d Calculated from ECGs presented in the report. Downloaded from by guest on October 14, 2016 699 Editorial Table 2 Comparison of QTc intervals in non-torsades de pointes series and the series of torsades de pointes reports Reference Number of cases Mean reported QTc (ms) (95% Confidence interval) Median reported QTc (ms) Range (ms) ............................................................................................................................................................................... Seth et al. 4 12 478 (+96) NS NS Abe et al. 5 17 NS 500 436– 581 Desmet et al. 6 Koji et al. 7 13 10 450*,† 555 (+46) 436 NS 310– 674 NS TdP reports presenting QTc (Table 1) 10 595* 635 326– 740 TdP reports maximal QTc (Table 1) 11 706† 730 425– 920 TdP, torsades de pointes; NS, not specified. *P ¼ 0.01 (two-tailed Student’s t-test). † P ¼ 0.00014 (two-tailed Student’s t-test). with, if not, a potential predictor for the development of TdP. Indeed if a cut-off of acute phase QTc .500ms is utilized then 9 of 11 TdP cases would have been predicted to be at risk (sensitivity 82%) and 11 of 13 non-TdP cases from Desmet’s series would have been predicted not to be at risk (specificity 85%). The presence of significant QT prolongation at other times than during the TCM episode in at least 4 of 11 TdP cases (36%) also suggests that there is an underlying predisposition towards repolarization abnormality: a reduced repolarization reserve.17 This term was first coined to describe the impact of QT prolonging drugs on predisposed individuals who then developed TdP. It is, therefore, reasonable to regard TCM as a similar transient acquired insult upon myocardial repolarization that may relate to an acute disturbance of cardiac autonomic function18 and precipitates TdP in more vulnerable individuals. In common with drug-induced LQTS, these individuals may carry clinically silent or unexpressed mutations implicated in the congenital LQTS or may harbour multiple common population variants that impair the repolarization reserve in more subtle ways.17 They may also have other predisposing abnormalities such as structural cardiac disease, metabolic disease, or bradycardia.17 There has been little genetic study in TCM at present, but systematic genetic research of TdP cases compared with non-TdP TCM is required to determine whether this phenomenon is driven by genotype and if so whether rare mutations or common variants are more important. This leaves open the future possibility of genetic testing assisting in determining the risk of TdP during acquired insults such as TCM. Management In the acute and subacute phases, it therefore appears reasonable to monitor the QT interval closely in individuals with possible TCM and if the QTc prolongs, particularly if it is .500ms, measures should be taken to monitor cardiac rhythm closely and prevent or treat TdP appropriately. As two of the cases were associated with bradycardia due to heart block, a known Conclusion These reports suggest that severe prolongation of the QT interval in TCM may be a marker for the risk of sudden death and should be monitored for in all suspicious cases. This may reflect an underlying abnormality of repolarization that may be genetic in basis and carry a risk of sudden death. Further research is required to study this hypothesis. Conflict of interest: none declared. References 1. Bybee KA, Kara T, Prasad A, Lerman A, Barsness GW, Wright S et al. Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation acute myocardial infarction. Ann Intern Med 2004;141: 858 –65. 2. Wedekind H, Müller JG, Ribbing M, Skurzewski P, Bozzetti C, Meyer-Krahmer HJ et al. A fatal combination in an old lady: Tako-Tsubo cardiomyopathy, long QT syndrome, and cardiac hypertrophy. Europace 2009;11:820 –2. 3. Mahida S, Dalageorgou C, Behr E. Long QT syndrome and Torsades de Pointes in a patient with Takotsubo cardiomyopathy: an unusual case. Europace 2009;11: 376 –8. 4. Seth PS, Aurigemma GP, Krasnow JM, Tighe DA, Untereker WJ, Mayer TE. A syndrome of transient left ventricular apical wall motion abnormality in the absence of coronary disease: a perspective from the United States. Cardiology 2003;100: 61 – 6. 5. Abe Y, Kondo M, Matsuoka R, Araki M, Dohyama K, Tanio H. Assessment of clinical features in transient left ventricular apical ballooning. J Am Coll Cardiol 2003;41: 737 –42. 6. Desmet WJ, Adriaenssens BF, Dens JA. Apical ballooning of the left ventricle: first series in white patients. Heart 2003;89:1027 –31. Downloaded from by guest on October 14, 2016 Takotsubo cardiomyopathy: another form of acquired long-QT syndrome precipitant of the acquired LQTS,17 temporary transvenous pacing should be considered as a therapeutic option.9 These cases also provide a useful indication to long-term management of these uncommon presentations of TCM. Given its transient nature and the female predominance, unless there are additional features suggestive of high risk LQTS (for example, a post-TCM QTc . 500ms, previous syncope, or previous cardiac arrest) then it is reasonable to advise treatment with a b-blocker alone. Otherwise an ICD may offer more appropriate long-term management. In the two cases of TdP and TCM that were complicated by high-degree AV block, the patients in question appeared to do well with permanent pacing alone after some improvement in their QT interval. 700 7. Koji M, Setsuya O, Eitaro F, Fumiya U, Atsunotu K, Toshikazu S et al. Evaluation of the arrhythmogenecity of stress induced ‘Takotsubo cardiomyopathy’ from the time course of the 12-lead surface electrocardiogram. Am J Cardiol 2003;92:230 –3. 8. Bonello L, Com O, Ait-Moktar O, Théron A, Moro PJ, Salem A et al. Ventricular arrhythmias during Tako-tsubo syndrome. Int J Cardiol 2008;128:e50– 3. 9. Kurisu S, Inoue I, Kawagoe T, Ishihara M, Shimatani Y, Nakama Y et al. Torsade de pointes associated with bradycardia and takotsubo cardiomyopathy. Can J Cardiol 2008;24:640 –2. 10. Ghosh S, Apte P, Maroz N, Broor A, Zeineh N, Khan IA. Takotsubo cardiomyopathy as a potential cause of long QT syndrome and torsades de pointes. Int J Cardiol 2008; Epub ahead of print 8 July 2008. 11. Furushima H, Chinushi M, Sanada A, Aizawa Y. Ventricular repolarization gradients in a patient with takotsubo cardiomyopathy. Europace 2008;10:1112 –5 [Epub 19 June 2008]. 12. Sasaki O, Nishioka T, Akima T, Tabata H, Okamoto Y, Akanuma M et al. Association of takotsubo cardiomyopathy and long QT syndrome. Circ J 2006;70: 1220 –2. Editorial 13. Denney SD, Lakkireddy DR, Khan IA. Long QT syndrome and torsade de pointes in transient left ventricular apical ballooning syndrome. Int J Cardiol 2005;100: 499 –501. 14. Mofrad PS, Rashid H, Tracy CM. New-onset QT prolongation and torsades de pointes accompanied by left ventricular dysfunction secondary to acute pancreatitis. Pacing Clin Electrophysiol 2003;26:1765 –8. 15. Nault MA, Baranchuk A, Simpson CS, Redfearn DP. Takotsubo cardiomyopathy: a novel ‘proarrhythmic’ disease. Anadolu Kardiyol Derg 2007;7 (Suppl 1): 101 –3. 16. Finstere J, St Stöllberger C, Sehnal E, Valentin A, Huber J, Schmiedel J. Apical ballooning (Takotsubo syndrome) in mitochondrial disorder during mechanical ventilation. J Cardiovasc Med (Hagerstown) 2007;8:859 –63. 17. Roden DM. Long QT syndrome: reduced repolarization reserve and the genetic link. J Intern Med 2006;259:59 –69. 18. Akashi YJ, Barbaro G, Sakurai T, Nakazawa K, Miyake F. Cardiac autonomic imbalance in patients with reversible ventricular dysfunction takotsubo cardiomyopathy. QJM 2007;100:335 – 43. Downloaded from by guest on October 14, 2016